Abstract
We assessed the incidence of circulating blasts occurring post-chemotherapy in 1000 consecutive pediatric blood samples. Blasts with myeloid morphology (<1-3%) were present in post-chemotherapy samples in 19 of 294 (6.4%) patients with acute leukemia in remission and in 11 of 361 (3.4%) patients with solid tumors, non-Hodgkin or Hodgkin lymphoma, and were associated with ANC > 1.5 × 109/l in 13 of 30 (43%) samples, and platelets > 100 × 109/l in 25 of 30 (83%) samples. Our findings suggest that the absence of circulating blasts may not be a prerequisite for remission in acute myeloid leukemia (AML).
| Original language | English |
|---|---|
| Pages (from-to) | 295-301 |
| Number of pages | 7 |
| Journal | Hematology |
| Volume | 8 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Oct 2003 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acute leukemia
- Blasts
- Chemotherapy
- Peripheral blood
- Remission
Fingerprint
Dive into the research topics of 'Circulating blasts following chemotherapy in pediatric patients: Implications for complete remission definition in acute leukemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver